190 related articles for article (PubMed ID: 30045668)
1. First Human Trial of High-Frequency Irreversible Electroporation Therapy for Prostate Cancer.
Dong S; Wang H; Zhao Y; Sun Y; Yao C
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789692. PubMed ID: 30045668
[TBL] [Abstract][Full Text] [Related]
2. High-Frequency Irreversible Electroporation for Intracranial Meningioma: A Feasibility Study in a Spontaneous Canine Tumor Model.
Latouche EL; Arena CB; Ivey JW; Garcia PA; Pancotto TE; Pavlisko N; Verbridge SS; Davalos RV; Rossmeisl JH
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785285. PubMed ID: 30071778
[TBL] [Abstract][Full Text] [Related]
3. Muscle contractions and pain sensation accompanying high-frequency electroporation pulses.
Cvetkoska A; Maček-Lebar A; Trdina P; Miklavčič D; Reberšek M
Sci Rep; 2022 May; 12(1):8019. PubMed ID: 35577873
[TBL] [Abstract][Full Text] [Related]
4. The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro.
Scuderi M; Rebersek M; Miklavcic D; Dermol-Cerne J
Radiol Oncol; 2019 Jun; 53(2):194-205. PubMed ID: 31194692
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
6. Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
van den Bos W; Jurhill RR; de Bruin DM; Savci-Heijink CD; Postema AW; Wagstaff PG; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna Pes MP; de Reijke TM; de la Rosette JJ
J Urol; 2016 Aug; 196(2):552-9. PubMed ID: 27004693
[TBL] [Abstract][Full Text] [Related]
7. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.
van den Bos W; de Bruin DM; Jurhill RR; Savci-Heijink CD; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna-Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
World J Urol; 2016 May; 34(5):657-64. PubMed ID: 26296371
[TBL] [Abstract][Full Text] [Related]
8. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
[TBL] [Abstract][Full Text] [Related]
9. Experimental and Numerical Investigation of Parameters Affecting High-Frequency Irreversible Electroporation for Prostate Cancer Ablation.
Aycock KN; Vadlamani RA; Jacobs EJ; Imran KM; Verbridge SS; Allen IC; Manuchehrabadi N; Davalos RV
J Biomech Eng; 2022 Jun; 144(6):. PubMed ID: 35044426
[TBL] [Abstract][Full Text] [Related]
10. Optimal parameters for the destruction of prostate cancer using irreversible electroporation.
Rubinsky J; Onik G; Mikus P; Rubinsky B
J Urol; 2008 Dec; 180(6):2668-74. PubMed ID: 18951581
[TBL] [Abstract][Full Text] [Related]
11. Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.
Murray KS; Ehdaie B; Musser J; Mashni J; Srimathveeravalli G; Durack JC; Solomon SB; Coleman JA
J Urol; 2016 Sep; 196(3):883-90. PubMed ID: 27113966
[TBL] [Abstract][Full Text] [Related]
12. The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy.
Miklavcic D; Pucihar G; Pavlovec M; Ribaric S; Mali M; Macek-Lebar A; Petkovsek M; Nastran J; Kranjc S; Cemazar M; Sersa G
Bioelectrochemistry; 2005 Feb; 65(2):121-8. PubMed ID: 15713562
[TBL] [Abstract][Full Text] [Related]
13. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.
Jarm T; Krmac T; Magjarevic R; Kos B; Cindric H; Miklavcic D
Biomed Eng Online; 2020 Nov; 19(1):85. PubMed ID: 33198769
[TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation: implications for prostate ablation.
Onik G; Mikus P; Rubinsky B
Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
[TBL] [Abstract][Full Text] [Related]
15. A Study on Nonthermal Irreversible Electroporation of the Thyroid.
Lv Y; Zhang Y; Huang J; Wang Y; Rubinsky B
Technol Cancer Res Treat; 2019 Jan; 18():1533033819876307. PubMed ID: 31564220
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
17. Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control.
Ting F; Tran M; Böhm M; Siriwardana A; Van Leeuwen PJ; Haynes AM; Delprado W; Shnier R; Stricker PD
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):46-52. PubMed ID: 26458959
[TBL] [Abstract][Full Text] [Related]
18. Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer.
Valerio M; Dickinson L; Ali A; Ramachadran N; Donaldson I; Mccartan N; Freeman A; Ahmed HU; Emberton M
J Urol; 2017 Mar; 197(3 Pt 1):647-654. PubMed ID: 27697580
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD
Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671
[TBL] [Abstract][Full Text] [Related]
20. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
